What Is Interventional Psychiatry?

· Updated November 2026 · Aazaz Haq, MD

Interventional Psychiatry

"Interventional psychiatry" is a newer term, and people sometimes ask me what it means and why my clinic uses it. Simply put, it is the part of psychiatry that treats illness with procedures, given in a clinic, rather than with pills taken at home.

The short answer

Interventional psychiatry treats mental illness with procedures given in a clinic, such as TMS, esketamine, ketamine, ECT and vagus nerve stimulation. It is mainly for people whose depression has not improved enough with standard medications and therapy. Good care in this field starts with a careful evaluation, not with the device.

What it includes

  • TMS: magnetic stimulation of mood circuits, FDA-cleared for depression and OCD.
  • Esketamine (Spravato): an FDA-approved nasal spray for treatment-resistant depression, given under supervision.
  • IV and IM ketamine: used off-label for depression in a monitored setting.
  • ECT: the most effective treatment for severe depression, given under anesthesia.
  • VNS: an implanted nerve stimulator for long-standing treatment-resistant depression.

These are not replacements for medications and therapy. They are added tools, often used alongside them.

Who it is for

Mostly people whose depression has not improved enough with standard treatment. In the largest real-world study of depression care, about a third of people reached remission with their first antidepressant, and the chances dropped with each additional medication. That leaves many people who need something different. Interventional psychiatry exists for them.

What good care looks like

The procedures get the attention, but in my experience the evaluation is where good care starts. Before choosing a treatment, someone should carefully review:

  • The diagnosis. Bipolar depression, trauma, sleep disorders, medical illness or substance use can all look like treatment-resistant depression.
  • What was actually tried, at what dose, for how long, and why it stopped.
  • Safety and current functioning.

Then the treatment should match the person, not the device the clinic happens to own. Good programs also measure progress, adjust when something is not working, and stay honest that no treatment helps everyone.

Why I built a clinic around it

Earlier in my career, I saw many patients who could have benefited from these treatments but could not get them. Access was the problem. McLean NTC exists to make these treatments available, with careful evaluation, monitoring and follow-up, and with insurance whenever possible. We are also a clinical training site for Georgetown University psychiatry residents.

We offer TMS, esketamine, IV and IM ketamine, VNS management and medication management. We refer for ECT when it is the right choice. Our guide to next steps after antidepressants shows how these fit together.

If you would like to know whether one of these treatments fits your situation, request a consultation call.

Questions I hear often

Do I need a referral?

No. You can contact us directly. Many people are referred by their psychiatrist, primary care doctor or therapist, and we keep those clinicians informed with your permission.

Will I stop seeing my current psychiatrist or therapist?

Not necessarily. Many patients continue with their existing clinicians while receiving treatment here. We coordinate so everyone is working from the same plan.

Is this only for depression?

Depression is our main focus. We also treat OCD with TMS and manage vagus nerve stimulation for people who have a device.

For referring clinicians

If you care for someone whose depression has not improved despite good treatment, we would be glad to help. I wrote two guides for colleagues:

Our referrals page explains how to send a patient and what we send back.

References

  1. Rush AJ, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006. PubMed
  2. Reif A, et al. Esketamine nasal spray versus quetiapine for treatment-resistant depression. N Engl J Med. 2023. PubMed
  3. Carpenter LL, et al. TMS for major depression: a multisite, naturalistic, observational study. Depress Anxiety. 2012. PubMed

Ready to take the next step?

Nothing here commits you to treatment. Start with a free consultation call with our patient advocate, who calls you back within one business day.

Or call us(571) 378-13986849 Old Dominion Drive, Suite 315, McLean
Call (571) 378-1398Request a consultation call